ORAGF yields 20618.56% · PFE yields 6.13%● Live data
📍 ORAGF pulled ahead of the other in Year 1
Combined, ORAGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ORAGF + PFE for your $10,000?
Monarca Minerals Inc., a mining company, engages in the acquisition, exploration, and development of silver projects in Mexico. Its flagship property is the Tejamen silver property consisting of 23 mineral concessions covering an area of approximately 1,685 hectares located to the northwest of Durango. The company also has an option agreement to acquire a 100% interest in the San Jose Project covering approximately an area of 5,580 hectares located in Chihuahua, northern Mexico. In addition, it holds 100% interest in the San Lucas property consists of 8 mineral concessions covering 79.6 hectares located to the north of the city of Durango. The company was formerly known as Oremex Silver Inc. and changed its name to Monarca Minerals Inc. in August 2016. Oremex Silver Inc. was incorporated in 1995 and is based in Toronto, Canada.
Full ORAGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.